Outcomes and complications associated with off-label and untested use of drug-eluting stents - Wikidata - wikimedia - TriplyDB

Outcomes and complications associated with off-label and untested use of drug-eluting stents

Outcomes and complications associated with off-label and untested use of drug-eluting stents

http://www.wikidata.org/entity/Q28301397

about

Clopidogrel: an updated and comprehensive review Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomize Selective versus exclusive use of drug-eluting stents in treating multivessel coronary artery disease: a real-world cohort study.Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries Drug-eluting versus bare-metal stents in unprotected left main coronary artery stenosis a meta-analysis.Relationship between red blood cell distribution width and intermediate-term mortality in elderly patients after percutaneous coronary intervention Medicare's policy on carotid stents limited use to hospitals meeting quality guidelines yet did not hurt disadvantaged.Sirolimus-eluting stents versus bare-metal stents in routine clinical use: a nonrandomized comparison.On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.Clinical outcomes in 995 unselected real-world patients treated with an ultrathin biodegradable polymer-coated sirolimus-eluting stent: 12-month results from the FLEX Registry.Safety and effectiveness of drug-eluting stents in Chinese patients with coronary artery disease with off- and on-label indications: results from a single-centre registry Safety of temporary and permanent suspension of antiplatelet therapy after drug eluting stent implantation in contemporary "real-world" practice Drug-eluting stents: a review of current evidence on clinical effectiveness and late complications.Use of noninvasive ventilation in patients with acute respiratory failure, 2000-2009: a population-based study.Off-label use of stents: bare-metal versus drug-eluting stents.Drug-eluting stent safety: findings from preclinical studies.A comparison of bare-metal and drug-eluting stents for off-label indications.A critical appraisal of the safety and efficacy of drug-eluting stents.Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent era.Percutaneous Coronary Intervention: Safety of Methotrexate and Its Possible Benefits on Restenosis After Bare-Metal Stent Deployment.Local drug delivery for treatment of coronary and peripheral artery disease.Long-term risk of clinical events from stenting side branches of coronary bifurcation lesions with drug-eluting and bare-metal stents: an observational meta-analysis.The management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery.Off-label use of drugs and medical devices: a review of policy implications.Perioperative antiplatelet management in patients with coronary artery stenting.Perioperative management of antiplatelet therapy in patients with drug-eluting stents.Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.One-Year Outcome of Everolimus-Eluting Stents Versus Biolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention.Current status and future trends in drug-eluting stents.Changes in the safety paradigm with percutaneous coronary interventions in the modern era: Lessons learned from the ASCERT registry.In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario.Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting Xience V stents in the randomized TWENTE trial: comparison of 2-year clinical outcome.Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period.Svelte integrated delivery system performance examined through diagnostic catheter delivery: the SPEED registry.The real world experience of the biodegradable polymer-coated sirolimus-eluting coronary stent system: Results From an "All-Comers" Clinical Experience.Toward defining the role of drug-eluting stents.

P2860

Q28219411-A15427CE-7AA4-4763-ADA2-BA6C97189B8E Q33649631-36AAFB2D-8F26-43E9-9C44-668D8A2DE731 Q34159834-2BD58C1C-2C2C-4686-A859-AFA51D56356B Q34207990-B980D601-7BC8-4168-8CB4-D4BBFD56EBCB Q34304853-8574F1C3-6DF1-4CCE-B6DB-A441FBB41198 Q34505408-FD6ADA17-7DF2-4601-9092-C9DBBA7EB826 Q34773417-25E6FDB1-0B03-4CC7-893E-E2B6259BD3FE Q35019663-0C761811-564C-4B96-9AA4-92D58CCCEE64 Q35189884-10E0CC47-5809-47C8-B17C-EF3477C5C3C1 Q35594795-D239E5A6-323A-46A6-A479-A3BF049815B1 Q35820167-304AD96A-F548-48B6-9DCA-3F87B874382E Q35878281-779E6666-77E3-40CC-91D1-1EA9D18137DD Q36602870-B762BDA3-4547-43AB-BE3D-4CDA87B0E333 Q36800865-8A6E4435-21F9-44EC-AC04-2D1A3CF36B63 Q37134004-EFB35102-8F96-4F06-94BE-B6F36A0248D4 Q37141941-474BF068-0BE8-4954-B603-3BA9837E1B4D Q37192220-8BFF19C8-0AD9-4857-851E-1099409A8ECA Q37269384-39F9ABF8-7046-4587-8802-6E60FD9133C9 Q37329149-07E1A150-1465-4B96-A520-3F4C3551981D Q37385456-61CD3379-05FD-4A5A-8C17-40E89D2DA242 Q37412922-9A24964E-C305-4F5B-ADE0-806491EA6AF8 Q37588002-AC925FF2-70C8-4931-8233-A2883DC38847 Q37629184-F0B8D72F-6B1F-407B-9E4C-766DF160B188 Q37765610-40370000-9067-4BAA-8756-FE296FB35ACC Q37786302-7133DB02-97E2-4F92-B05D-E80AC60876E6 Q37808050-3DBCA6C1-05A1-477C-8B9F-FC8B068C0AF9 Q37999651-D05CD373-DF47-4AF1-AB95-5474EF925ADA Q38012080-07A8790A-DE41-4630-ABF1-46B31E2CB0F1 Q38084549-D07D779A-0731-4B09-88E9-8788591936C1 Q38398230-301763A5-15A6-4E43-8014-EF7A711CE2D5 Q39121381-EFA186CC-4D26-4663-A56D-F4157E099446 Q40187039-0335A212-A9ED-4C50-91CB-5862E144F389 Q42322686-31C91DB8-BB22-46F7-B81D-BF87C171D7FC Q44668746-C18BD548-58DB-45D8-8618-0CF6B1674C10 Q45846827-0D15095A-825D-4A08-BBC5-D88B934A5E2B Q45876240-2FB5A5C6-F859-45D3-AF7B-F64073D15696 Q45930222-5B9127D3-50A3-44CC-BFF7-5BAAD65B4997 Q50640809-80F20C1D-D460-49AA-83BD-425155D8F2B5 Q50747273-DC450902-B413-4395-966E-C8602D9EA987 Q50944347-E07AB85F-2270-48B4-93D8-7A36F67F4634

P2860

Outcomes and complications associated with off-label and untested use of drug-eluting stents

http://www.wikidata.org/entity/Q28301397

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Outcomes and complications ass ...... ted use of drug-eluting stents

@ast

Outcomes and complications ass ...... ted use of drug-eluting stents

@en

Outcomes and complications ass ...... ted use of drug-eluting stents

@nl

type

label

Outcomes and complications ass ...... ted use of drug-eluting stents

@ast

Outcomes and complications ass ...... ted use of drug-eluting stents

@en

Outcomes and complications ass ...... ted use of drug-eluting stents

@nl

prefLabel

Outcomes and complications ass ...... ted use of drug-eluting stents

@ast

Outcomes and complications ass ...... ted use of drug-eluting stents

@en

Outcomes and complications ass ...... ted use of drug-eluting stents

@nl

P1433

Q28301397-87A942A4-2398-433A-B21B-E63A39B442AD

P1476

Q28301397-C5DC9785-C43B-4E55-ADE0-DD1336803E3E

P2093

Q28301397-02DB6ED4-EBED-4E43-89E1-4FEDEA334CBC

Q28301397-1CBB7A2C-12AF-4896-BD3D-8363586D92EC

Q28301397-4DCC5484-926A-451F-B2FE-8F92472D456A

Q28301397-611E8D91-3AEE-43C9-8F07-1C891C17F207

Q28301397-6CC21F0D-44C3-43CB-A3A1-2CFA841F357D

Q28301397-7237BDBB-C00F-4F9B-A77A-4F3EBD3CE3DD

Q28301397-DA2CE5C1-391A-4E38-8D4C-F5C5D5E47AC5

Q28301397-E3FEB0D9-2769-4138-8516-AD07D9AC53E5

Q28301397-EDD84BAB-F8B4-4415-9F7D-B39B4339EFBB

Q28301397-F4C8CC25-B90A-40C7-8624-28D404D21247

P304

Q28301397-A6C515CA-36D4-480B-B0BE-C9512A110CF4

P31

Q28301397-BFFDB176-2673-4280-89F4-B44AF8F2485A

P3181

Q28301397-D4919DA5-2BFE-4DAA-B3E8-08795A482851

P356

Q28301397-55F74303-AE19-4FDB-A5AC-AAD0CFA036A2

P407

Q28301397-645D1FAE-EA1A-4C80-9D84-1D74C3260E2A

P433

Q28301397-A429A147-A69B-4113-8C12-B9444E4D0EE5

P478

Q28301397-0E20F1E5-626A-454D-A50A-BB42918998A1

P577

Q28301397-F0FB71BC-2B90-4757-9313-561080A579CE

P5875

Q28301397-4F7B1129-5CC0-4F8A-A9BC-D97CC9D9A9A2

P698

Q28301397-2209AE03-898A-40A0-BFA1-490088780F60

P3181

P356

JAMA.297.18.1992

P1433

Journal of the American Medical Association

P1476

Outcomes and complications ass ...... ted use of drug-eluting stents

@en

P2093

Charles J Davidson

http://www.w3.org/2001/XMLSchema#string

Charles L Bennett

http://www.w3.org/2001/XMLSchema#string

David O Williams

http://www.w3.org/2001/XMLSchema#string

Helen Aslanidou Vlachos

http://www.w3.org/2001/XMLSchema#string

James D Flaherty

http://www.w3.org/2001/XMLSchema#string

Keith H Benzuly

http://www.w3.org/2001/XMLSchema#string

Kevin E Kip

http://www.w3.org/2001/XMLSchema#string

Lynne Goodreau

http://www.w3.org/2001/XMLSchema#string

Mark J Ricciardi

http://www.w3.org/2001/XMLSchema#string

Nirat Beohar

http://www.w3.org/2001/XMLSchema#string

P304

1992-2000

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4746803

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMA.297.18.1992

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

297

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6342427

http://www.w3.org/2001/XMLSchema#string

P698

17488964

http://www.w3.org/2001/XMLSchema#string